Viromed Medical AG | WebDisclosure

Switch to English

11330	Sociétés
251809	Mots-clés
181030	Articles
137587	Communiqués

Accueil
Sociétés
Viromed Medical AG

COMMUNIQUÉ DE PRESSE

publié le 28/08/2026 à 15:54, il y a 2 mois 15 jours

Viromed Medical AG receives ÜTS registration for ViroCAP® in Turkey and can fulfill existing orders
Viromed Medical AG receives ÜTS registration for ViroCAP® in Turkey, enabling fulfillment of existing orders. The cold plasma device offers contact-free application of plasma in medical care settings

Turkey Viromed Medical AG Cold Plasma Technology ViroCAP ÜTS Registration
BRÈVE

publiée le 27/08/2026 à 08:32, il y a 2 mois 16 jours

Viromed Medical AG: Uwe Perbandt's Financial Influence

Strategic Development Financial Stability Viromed Medical AG Cold Plasma Technology Uwe Perbandt
BRÈVE

publiée le 27/08/2026 à 08:32, il y a 2 mois 16 jours

Viromed Medical AG : L'influence financière d'Uwe Perbandt

Stabilité Financière Développement Stratégique Viromed Medical AG Technologie Du Plasma Froid Uwe Perbandt
COMMUNIQUÉ DE PRESSE

publié le 27/08/2026 à 08:27, il y a 2 mois 16 jours

Viromed Medical AG: CEO and founder Uwe Perbandt has supported the company for years as a long-term financier
Viromed Medical AG CEO Uwe Perbandt long-term financier; EUR 16.6 million funding secure financial stability and working capital, repayment of loan liabilities

Financing CEO Viromed Medical AG Uwe Perbandt Long-term Financier
BRÈVE

publiée le 25/08/2026 à 08:07, il y a 2 mois 18 jours

Viromed Medical AG prévoit des placements d'actions pour renforcer son financement

Viromed Medical AG Technologie Du Plasma Froid Uwe Perbandt Placements D'actions Expansion De La Base D'investisseurs
BRÈVE

publiée le 25/08/2026 à 08:07, il y a 2 mois 18 jours

Viromed Medical AG Plans Share Placements to Bolster Financing

Investor Base Expansion Viromed Medical AG Cold Plasma Technology Uwe Perbandt Share Placements
COMMUNIQUÉ DE PRESSE

publié le 25/08/2026 à 08:02, il y a 2 mois 18 jours

Viromed Medical AG: Further share placements from the holdings of the CEO and founder to support additional financing of ongoing operations
Viromed Medical AG plans further share placements to support ongoing operations and strengthen working capital. CEO Uwe Perbandt aims to finance growth and establish cold plasma technology in various applications

Finance Viromed Medical AG Cold Plasma Technology Share Placements CEO Uwe Perbandt
BRÈVE

publiée le 10/08/2026 à 16:01, il y a 3 mois 2 jours

Viromed Medical AG Expands with New Distribution Partnerships

Market Expansion Distribution Partnerships Viromed Medical AG Cold Plasma Technology ViroCAP®
BRÈVE

publiée le 10/08/2026 à 16:01, il y a 3 mois 2 jours

Viromed Medical AG se développe grâce à de nouveaux partenariats de distribution

Partenariats De Distribution Viromed Medical AG Expansion Du Marché Technologie Du Plasma Froid ViroCAP®
COMMUNIQUÉ DE PRESSE

publié le 10/08/2026 à 15:56, il y a 3 mois 2 jours

Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets
Viromed Medical AG signs distribution partnerships for ViroCAP® in six additional markets, expanding international presence with new agreements for cold plasma technology

Distribution Partnerships International Presence Viromed Medical AG Cold Plasma Technology ViroCAP®

Les Echos

Publié le 12/11/2026 à 08:56, il y a 8 heures 31 minutes

Number of shares and voting rights - October 2026 (In French only)
Publié le 12/11/2026 à 08:56, il y a 8 heures 31 minutes

Nombre total d'actions et droits de vote - octobre 2026
Publié le 12/11/2026 à 08:40, il y a 8 heures 48 minutes

FREY forms a €400 million equity partnership with GIC to invest in premium European retail parks
Publié le 12/11/2026 à 08:40, il y a 8 heures 48 minutes

FREY et GIC s’associent pour investir 400 M€ de capital dans les retail parks premium en Europe
Publié le 10/11/2026 à 18:00, il y a 1 jour 23 heures

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 12/11/2026 à 15:55, il y a 1 heure 33 minutes

DIAGENS Leads in Two Major Global AI Benchmarks and Extends Chest and Abdominal CT Analysis to 509 Imaging Targets, Ushering in a New Era for Medical Imaging AI
Publié le 12/11/2026 à 14:31, il y a 2 heures 57 minutes

First Breach Inc. Announces Third Quarter 2026 Earnings Conference Call
Publié le 12/11/2026 à 14:00, il y a 3 heures 28 minutes

GameSquare Announces Peaky Blinders Digital Fan Experience, Advancing the Company's IP Monetization Strategy
Publié le 12/11/2026 à 14:00, il y a 3 heures 28 minutes

NuRAN Wireless Highlights Recurring Revenue Economics and Growth Potential of Its 5,092-Tower Contracted NaaS Portfolio
Publié le 12/11/2026 à 13:45, il y a 3 heures 43 minutes

Amarc and Freeport Successfully Complete 2026 Joy Copper-Gold District Exploration Program

Voir tout ACCESSWIRE

EQS Group

Publié le 12/11/2026 à 17:17, il y a 11 minutes

Holding(s) in Company
Publié le 12/11/2026 à 16:40, il y a 47 minutes

Rockwell Automation Introduces LogixEdge Controllers for Software-Defined Automation
Publié le 12/11/2026 à 16:29, il y a 58 minutes

Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice
Publié le 12/11/2026 à 16:06, il y a 1 heure 22 minutes

Leadership change at GEA: Klaus Stojentin to succeed Stefan Klebert as CEO
Publié le 12/11/2026 à 16:05, il y a 1 heure 22 minutes

Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence